tiprankstipranks
Immix Biopharma, Inc. (IMMX)
NASDAQ:IMMX
US Market
Holding IMMX?
Track your performance easily

Immix Biopharma, Inc. (IMMX) Financial Statements

127 Followers

Immix Biopharma, Inc. Financial Overview

Immix Biopharma, Inc.'s market cap is currently ―. The company's EPS TTM is $-0.875; its P/E ratio is -2.48; Immix Biopharma, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -7.14M$ -4.40M$ 5.86M$ -4.34M$ -3.59M
EBITDA$ -7.11M$ -4.37M$ 5.88M$ -4.34M$ -3.59M
Net Income Common Stockholders$ -7.15M$ -4.39M$ -5.26M$ -4.28M$ -3.58M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 19.69M$ 23.98M$ 29.32M$ 19.58M$ 12.65M
Total Assets$ 25.14M$ 28.84M$ 34.35M$ 22.47M$ 15.57M
Total Debt$ 1.09M$ 1.09M$ 1.09M$ 0.00$ 0.00
Net Debt$ -18.60M$ -22.88M$ -28.23M$ -19.58M$ -12.65M
Total Liabilities$ 7.59M$ 4.94M$ 6.72M$ 2.83M$ 2.40M
Stockholders Equity$ 17.55M$ 23.89M$ 27.92M$ 19.77M$ 13.23M
Cash Flow-
Free Cash Flow$ -4.31M$ -5.35M$ -4.13M$ -3.13M$ -3.52M
Operating Cash Flow$ -4.04M$ -5.26M$ -3.83M$ -3.09M$ -3.52M
Investing Cash Flow$ -271.54K$ -97.07K$ -301.91K$ -38.91K-
Financing Cash Flow--$ 15.95M$ 10.07M$ 4.69M
Currency in USD

Immix Biopharma, Inc. Earnings and Revenue History

Immix Biopharma, Inc. Debt to Assets

Immix Biopharma, Inc. Cash Flow

Immix Biopharma, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis